CLINICAL_TRIALS
trial_result
· 2015-01-13
Clinical Trial Update: Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer [Phase 2]
Summary
A Phase 2 trial evaluating adding sorafenib to existing endocrine therapy in advanced breast cancer was terminated, with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Suleiman Massarweh | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2015-01-13